08/03/201621/10/2023 Helix BioPharma Corp. Reports on Advancement of Its L-DOS47 Phase I/II Study in Poland admin 0 Comments
03/03/201621/10/2023 Helix BioPharma Corp. Reports on Advancement of its Lung Cancer Drug Candidate L-DOS47 admin 0 Comments